Primary thymic mucosa-associated lymphoid tissue lymphoma complicated with renal amyloidosis

Abstract Introduction: Primary mucosa-associated lymphoid tissue (MALT) lymphomas originating in thymus is rare. And, there have been few reports of patients with MALT coexisting with amyloidosis. As far as we know, this was the first case report on MALT lymphoma associated with renal amyloidosis. Patient concerns: A 57-year-old man presented with nephrotic syndrome. Further workup revealed IgM-Lambda type monoclonal gammopathy. Bone marrow biopsy showed 8% clonal plasma cells. Renal biopsy confirmed the diagnosis of Lambda light chain AL amyloidosis. positron emission tomography/computed tomography showed thymic lesions which upon biopsy were diagnosed as MALT lymphoma of the thymus. Diagnosis: Primary thymic MALT lymphoma complicated with renal amyloidosis. Interventions: The patient underwent surgical resection of the thymus mass and 2 courses of chemotherapy. Outcomes: Follow-up data showed that the patient survived 18 months after surgical excision and chemotherapy. Conclusion: The case highlights the importance of screening for malignancy in patients with renal amyloidosis.

[1]  D. Dingli,et al.  Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[2]  T. Zhu,et al.  The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients. , 2016, Leukemia research.

[3]  J. Goujon,et al.  Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  S. Goel,et al.  Diffuse large B cell lymphoma with high M protein: an unusual finding , 2015, Blood research.

[5]  M. Hirokawa,et al.  Cytologic findings and differential diagnoses of primary thyroid MALT lymphoma with striking plasma cell differentiation and amyloid deposition , 2014, Diagnostic cytopathology.

[6]  C. Fletcher.  The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification , 2014, Histopathology.

[7]  P. Liu,et al.  Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma , 2013, Medical Oncology.

[8]  M. Sunohara,et al.  Mucosa associated lymphoid tissue (MALT) lymphoma of the thymus with trisomy 18. , 2009, Internal medicine.

[9]  A. Horwich,et al.  Gemcitabine, cisplatin and methylprednisolone for the treatment of patients with peripheral T-cell lymphoma: the Royal Marsden Hospital experience. , 2007, Haematologica.

[10]  Evangelia Dimitriadou,et al.  Differential diagnosis of Waldenstrom's macroglobulinemia and other B-cell disorders. , 2005, Clinical lymphoma.

[11]  T. Economopoulos,et al.  Monoclonal gammopathies in B-cell non-Hodgkin's lymphomas. , 2003, Leukemia research.

[12]  T. Therneau,et al.  Long-term follow-up of IgM monoclonal gammopathy of undetermined significance. , 2003, Blood.

[13]  R. Kyle,et al.  The spectrum of IgM monoclonal gammopathy in 430 cases. , 1987, Mayo Clinic proceedings.

[14]  P. Isaacson,et al.  Malignant lymphoma of mucosa‐associated lymphoid tissue. A distinctive type of B‐cell lymphoma , 1983, Cancer.